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A Measure to Determine Acceptable Workload for Increasing Operational Efficiencies for 
the Conduct of Clinical Trials 
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Duquesne University  
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Abstract 
As the demands for the conduct of clinical trials rise, it becomes increasingly important to 
establish a quantitative means of estimating the appropriate staffing resource to coordinate trial 
related activities. There has been a limited amount of research conducted to evaluate methods or 
tools to measure workload in the clinical trial setting. A literature search revealed a gap in the 
literature about tools used to measure workload and its impact on clinical trial performance and 
job satisfaction. The aim of this pilot project was to test the Ontario Protocol Assessment Level 
(OPAL) complexity rating tool in generating quantitative measurements of workload for the 
purpose of assessing operational efficiencies and identifying opportunities for process 
improvement changes. The pilot project was conducted in a clinical trials unit consisting of 
clinical research nurses (CRN), clinical research coordinators (CRC) and research managers who 
participated in the project implementation. Concepts from the Institute for Healthcare 
Improvement (IHI) Model for Improvement and Plan-Do-Study-Act (PDSA) were used to guide 
project implementation and Lean principles for the interpretation of data findings. The findings 
from the data showed that OPAL can be used as a quantitative means to measure workload, and 
to assess factors affecting operational efficiencies.   
Keywords: workload, workload measurement, clinical trials, clinical research 
coordinator, clinical research nurse, skill-mix 
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A Measure to Determine Acceptable Workload for Increasing Operational Efficiencies for 
the Conduct of Clinical Trials 
According to Casner and Gore (2010), “[h]umans who are overburdened with work tend 
to hurry their performance, commit more errors, yield poor accuracy, become frustrated, 
uncomfortable, and fatigued, and have poor awareness of their surroundings”…“[i]nterestingly, 
humans who are underworked can exhibit many of the same symptoms” (p. 1). Therefore, a 
balanced distribution of work would likely lead to greater productivity and efficiency. They 
emphasized the need for a device to measure workload that “would allow us to approach any 
work situation and acquire a numerical (or at least ordinal) measure of the level of workload 
being experienced by a human operator” (Casner & Gore, 2010, p. 1). In parallel, they stated the 
need to define “practical and sensible limits for workload”, emphasizing that in order to make 
scientific inferences about numerical measurements of workload levels that these terms need to 
be more rigorously defined (Casner & Gore, 2010, p. 1).   
According to Milani et al. (2017) “few resources are available to quantify clinical trial-
associated workload, needed to guide staffing and budgetary planning” (p. 1). They further 
stated, that “the total number and frequency of procedures specified in each clinical trial 
protocol…is increasing annually” and affecting the workload of clinical research personnel 
required to perform these activities (Milani et al., 2017, p. 1). The lack of a method for 
measuring the needs of patients participating in clinical trials hinders the ability of managers in 
making precise staffing and budget projections and resource allocation decisions (Brennan et al., 
2019). Additionally, Brennan et al. (2019) indicated that when aspects of workload that affect 
workflow and efficiency are not measured, these have the potential in impacting quality of care, 
patient safety, and the integrity of research outcomes. This pilot project was implemented in a 
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clinical trials unit to test and evaluate a workload measurement instrument for generating 
workload related metrics that could be used to assess factors that impact staff performance and 
job satisfaction and identify opportunities for process improvement changes to enhance overall 
clinical trial performance.  
Clinical Research Problem 
The basis for this pilot project was the recurring need for research managers of a clinical 
trials unit to accurately predict staffing requirements and assess work capacity of clinical 
research staff.  As a result, the research staff can more efficiently coordinate complex phase I 
cancer trials for novel high-risk cell-based therapies (i.e., genetically modified CAR T cells) used 
to treat a variety of cancer types – hematologic and solid tumor malignancies. This notion 
provides a more precise estimation of the work capacity of research staff that facilitates a more 
balanced distribution of work, resulting in greater staff productivity, efficiency and effectiveness, 
better overall clinical trial performance, and a reduction in work-related stress. Additionally, 
workload measurements could inform more efficient and cost-effective utilization of staff in 
accomplishing clinical trial deliverables and meeting project timelines. Historically, research 
managers from this clinical trials unit have relied primarily on their intuition and experience in 
assessing feasibility for trial activation and estimating staff capacity for allocation of work 
assignments. Feasibility assessments are largely based on the projected trial participant sample 
size and intensity of study visit requirements. An accurate estimation of staffing requirements 
ensures a safer conduct of clinical trials, high-quality study outcomes, enhances staff efficiency 
and productivity, and reduces work-related stress and operational costs. For many cancer patients 
with late stage or advanced disease, participation in clinical trials provide them access to 
alternative investigational therapies in addition to routine care cancer therapies or in place of 
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standard of care modalities that are no longer effective in preventing the progression of their 
disease or resulting in durable remission of their cancer. Administration of investigational 
therapies can provide benefits in slowing down disease progression, extending quality of life or 
in some cases resulting in complete remission of cancer. 
According to Malik and Lu (2019), “[p]hase I protocols are known to be the most 
complex and burdensome to conduct” citing that “[c]ontemporary therapies in cancer phase I 
trials are subject to newer endpoints with an effort to demonstrate a response signal or at least 
evidence of target inhibition” (p. 519). They evaluated a total of 102 phase I protocols that were 
active in 1996, 2006 and 2016 and found that there were significantly higher numbers of trial 
procedures in the protocols from 2016 compared with 2006 and 1996 (P<0.001); 90% of these 
trials were testing immune or targeted therapies (Malik & Lu, 2019). Drug development in 
oncology continues to grow as the standard treatment for many cancers rapidly evolves to 
include novel targeted therapies, immunotherapies, antibody-drug conjugates and chimeric 
antigen T cell receptors (CARs) (Malik & Lu, 2019). The Food and Drug Administration is 
granting breakthrough designations and conditional approvals based on phase I and II clinical 
trial data, and as such the development process “should be rapid, efficient and able to implement 
modern drug development models for upcoming novel drugs” (Malik & Lu, 2019, p. 519). 
However, “[a]n efficient and successful phase I research program can be challenging in light of 
an increase protocol complexity, restrictive inclusion and exclusion criteria, high personnel 
workload, stringent regulatory criteria and a restrictive budget to manage the work” (Malik & 
Lu, 2019, p. 519). 
It is important to quantify workload because the design of phase I trials have substantially 
increased study requirements making them more complex over the last 20 years (Malik & Lu, 
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2019). In a study conducted to measure protocol design trends by the Tufts Center for the Study 
of Drug Development (CSDD), they observed that the number of unique procedures had 
increased at the annual rate of 6.5% and the frequency of procedures per protocol by 8.7% (Getz 
et al., 2008). In the same study, they found that “investigative site work burden to administer 
each protocol increased at an even faster rate of 10.5%” (Getz et al., 2008, p. 450). They 
described how these protocol changes over time have had an impact on clinical trial performance 
but have not been sufficiently quantified (Getz et al., 2008). According to Milani et al. (2017), 
“[t]he assessment of the correct balance between size of workforce and number of trials is 
therefore essential to ensure on the one hand patient safety and on the other data quality” (p. 7). 
Project Purpose 
 
The purpose of the pilot project was to evaluate the use of a quantitative measurement 
tool for assessing clinical trial workload, and to identify opportunities for process change and 
improvement, while promoting job satisfaction.  
Project AIMS 
1. Utilize OPAL to assess workload of research personnel involved in clinical trial 
implementation 
2. Use data from OPAL to evaluate operational efficiencies impacting clinical trial 
performance  
3. Identify other factors affecting staff efficiency and job satisfaction 
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Project Objectives 
1. Use PDSA cycle to test and study OPAL as a method for measuring clinical trial 
complexity and workload  
2. Use PDSA cycle to assess three factors from OPAL measurements that increase staff 
effort and impact operational efficiency 
3. Use PDSA cycle to 
• Identify and evaluate three dimensions from a job stress survey that impact staff 
efficiency and contribute to job stress 
• Assess other factors identified from a review of protocol deviations reported for 
four of the ten protocols in our project sample that may affect staff efficiency and 
job stress 
4. Use Lean principles to interpret project findings and make recommendations for process 
improvement changes and goals, and improving job satisfaction 
Review of the Literature 
A literature search was conducted using PubMed, CINAHL, Google Scholar, Google and 
Bing. The initial search used terms such as staffing ratio, staffing models, clinical research nurse, 
clinical trial and caseload. Emulating the concept of the nurse-to-patient ratio, the search focused 
on methods to determine a balanced distribution of trial protocols assigned to research personnel. 
The early search generated studies conducted in more traditional and acute patient care settings, 
such as the intensive care, pediatrics and medical-surgical units. These studies evaluated methods 
for quantifying nurse staffing requirements based on ratio of patients to nurse or nursing hours 
per patient day. Additionally, some studies suggested consideration of skill-mix utilizing 
unlicensed assistive personnel to perform duties or tasks not requiring the completion by a 
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registered nurse. Although the methods and findings from these studies could not be directly 
correlated to the circumstances that were specific to the clinical trial setting, the concept of 
balanced work distribution and skill-level mix was relevant.  
Search terms were later refined to include workload, workload measurement, staffing 
model, staffing ratio, skill-mix and clinical trials. Studies assessing workload and evaluating 
workload measurement tools specific to the clinical trial setting were identified through a 
snowball search. A total of six level II and level III good and high-quality studies were identified 
and determined to be directly related to the project topic and adequately supported the aims for 
this pilot project. However, it is notable that a gap in the literature for studies evaluating 
workload measurement tools and the impacts that workload has on clinical trial performance still 
exist.  
A thorough review and appraisal of the literature that directly supported the aims of this 
pilot project were performed. A summary of the synthesis and appraisal of the literature is 
provided in Appendix A. The appraisal of the level and quality of the literature was performed 
according to the criteria described in Johns Hopkins Nursing Evidence-Based Practice: Models 
and Guidelines (Dang & Dearholt, 2018). 
Synthesis of the Literature 
Due to the unique methods described in each study for the measurement of workload, it 
was important to include a summary of each tool or instrument described to provide better 
context for the literature synthesis. 
In a study conducted by Smuck et al. (2011), they tested the Ontario Protocol Assessment 
Level (OPAL) complexity rating tool to measure trial complexity, case and total workload. Their 
study was aligned with the Ontario Institute for Cancer Research’s mission for “process of 
A MEASURE TO DETERMINE ACCEPTABLE WORKLOAD  9 
improvements necessary to promote speed, quality, and accessibility of clinical trials for patients 
in Ontario” and to assist clinical research professionals in working together to navigate through 
the very complicated demands for conducting clinical research (Smuck et al., p. 80). OPAL 
measured trial complexity and assigned a complexity level score based on criteria listed on a 
pyramid scale. A working group of experienced clinical trial managers was assembled to develop 
the standard rating scale for their tool to measure trial complexity that would later be applied to 
measuring workload. The guiding principles for their tool were its ease of use, specificity to 
measure work directly related to clinical trial professionals, usefulness in calculating workload 
capacity for different phase trials but not be intended for academic review. The tool is based on a 
pyramid scale that rates the complexity level of trial protocols from the least to the most 
complex. They conducted the pilot testing for this tool across several of Ontario’s clinical trials 
sites with the aim of demonstrating that “OPAL was reliable, and that scoring was consistent 
across clinical trial protocols and across sites” (Smuck et al., 2011, p. 81).  Their analysis of the 
scores from 176 OPAL assessments left them to conclude that a variance of up to 1.5 between 
the scores was acceptable, with only two trials shown to have a variance of 3.5.  The 
acceptability of a 1.5 variance was based on the research practice models of each site and 
correlative studies associated with the protocol.  Their review of the scores revealed that 
misinterpretation of the definitions of the parameters used to rate the complexity levels resulted 
in higher OPAL scores.  Hence, they emphasized that “OPAL needs to be applied consistently at 
the site and should be based on local practices to produce measurable site workload information” 
(Smuck et al., p. 81). At the conclusion of their pilot project OPAL was revised to more 
accurately reflect the clinical trial activity reported by the sites. OPAL provides “an objective 
method of quantifying clinical trials activity on the basis of factors that contribute to increased 
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workload,” however, “total workload of staff varies, and workload needs to be reviewed 
quarterly to reflect fluctuation in cases” (Smuck et al., 2011, p. 83). 
Sarmento and Silvino (2017) conducted a Portuguese transcultural adaptation and 
validation study of OPAL. They indicated that because of the significant increase in the growth 
of clinical research in Brazil the development of indicators that can inform about the quality of 
work, support evaluation of performance and necessary changes to the existing processes is 
essential. Due to lack of any instruments to measure workload of clinical research coordinators 
in Brazil, they aimed to test a transculturally adapted version of OPAL to verify its validity and 
reliability. Their goal was to be able to better distribute oncology trial protocols among clinical 
research coordinators that would facilitate them to fulfill the requirements for the trials, as well 
as identifying the capacity that would require redistribution of protocols and competency training 
of staff. Their methods included front and back translation of the OPAL tool in Portuguese and 
conducting a pre-test of the adapted instrument on 15 fictitious protocols in order to define the 
workload score to set as the gold standard for evaluating the psychometric capacity of the 
instrument. The final version of the adapted instrument was analyzed to measure the 
psychometric capacity of the instrument – both reliability and validity of the tool. The numerical 
data were analyzed using descriptive statistics and concordance of workload scores pertaining to 
different observed items using inferential statistics, with a 95% confidence interval. Analysis of 
concordance of observed items included the differences of intra- and inter-observer variability 
against the average result. The result of their analysis showed a significantly high intra- and 
inter-observer concordance (p<0.0001). The intra-observer analysis resulted in a high level of 
concordance with ICC scores between 0.987 and 0.934 indicating high reliability. The inter-
observer analysis showed high level of concordance compared to the gold standard with an 
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ICC>0.949 that demonstrated high level of validity of the score. They acknowledged that the 
absence of a validated tool to calculate workload can result in unrealistic expectations, 
unmanageable workload and inefficient use of available resources. They concluded that although 
the adapted OPAL tool met the needs of the users in calculating workload, it is important to be 
used consistently and that managers allocating protocol assignments evaluate other factors that 
affect the work of clinical research staff. 
In a study conducted by Milani et al. (2017), they tested the application of the Nursing 
Time Required by Clinical Trial–Assessment Tool (NTRCT-AT). This was a single center study 
in which the aim was to evaluate this tool as a means to measure workload expressed in time 
spent to complete trial associated core activities. They identified 30 clinical trial core activities, 
with 11 related to the trial activation phase and the remainder to study conduct. These 30 core 
activities were associated with the clinical research nurse’s role in coordinating activities of a 
clinical trial. The NTRCT-AT measured the average times required to complete each of the core 
activities – expressed as a standard coefficient of time required to perform each activity. 
NTRCT-AT was used to calculate the total clinical trial nursing time required for coordinating 
study activities for each study participant enrolled in the trial. They had five phases for study 
implementation that included the identification of aims, determination of study methods, 
identification of core activities from the literature and site staff experience, timing of each of the 
core activities using an objective external observer, data collection and review of the standard 
co-efficient of time for each activity to calculate average time it took in effort to coordinate the 
participation of each individual participant. Their study showed that the earlier and more 
advanced phases of the trials were similar in content – meaning the types of core activities were 
similar. However, the timing and complexity differed due to the difference in the number of 
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procedures among various study visit intervals, and the frequency of study visits between 
different trials. The NTRCT-AT was geared for measuring time commitments of personnel 
coordinating phase I and III trials. Their data showed that phase I trials required more time for 
study staff to complete trial activities during the activation phase. However, a weakness of their 
study was the lack of generalizability of their data since the study was only conducted in one 
research facility. Nevertheless, their study illustrated that the increasing demands of clinical 
research necessitated an adequate number of skilled and competent workforce to be involved in 
each trial. 
Good, Lubejko et al. (2013) acknowledged that “[c]oordination of an efficient, successful 
clinical research program can be challenging” and is compounded by the “lack of resources for 
quantifying clinical-trial associated workload to help guide staffing and budgetary planning” (p. 
211). Therefore, the use of a tool that generates objective metrics to measure workload could 
potentially increase clinical research program productivity, efficiency and quality of work, while 
providing managers a guide for calculating staffing and budgetary requirements, as well as 
evenly distributing work among staff resulting in job satisfaction (Good, Lubejko et al., 2013).  
They described the evaluation of an acuity-based workload assessment tool developed and 
implemented to facilitate assessment and balance of workload among research staff. The tool 
known as the Witchita Community Clinical Oncology Program Acuity Tool (WPAT) was 
developed by the Witchita Community Clinical Oncology Program (WCCOP). The tool 
classified study participants into two categories, on a study or off a study. The total number of 
on- and off-study patients constituted the overall workload. Additionally, protocols were 
classified as either a treatment- or cancer-control trial and were assigned a score based on six-
workload determinants that included treatment complexity, study procedure requirements, 
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treatment toxicity potential, complexity and number of data forms, degree of coordination 
required and number of trial random assignments or steps. Development of the tool was based on 
a patient classification system that was used to determine workload and staffing assignments. 
The calculation of the acuity scores took place monthly and required multiplying the protocol 
classification score for each study by the number of active patients from the study that was 
assigned to staff. Acuity score calculations were conducted over a period of 11 years. Review of 
the acuity scores over the 11-year period confirmed that the complexity of clinical trials had 
increased – acuity for treatment trials by 65% from 1999 to 2009 and cancer control by 181% for 
the same time period (Good, Lubejko et al., 2013). The number of newly enrolled and on-study 
patients assigned per full-time staff decreased as result of continual monitoring of workload and 
adjustment of workload based on acuity scores. This demonstrated that “[m]onthly monitoring of 
individual as well as group average acuity scores provided management with the ability to 
balance workload among staff” (p. 213). 
Good, Hurley et al. (2016) described a project sponsored by the American Society of 
Clinical Oncology to evaluate the feasibility and utility of a workload measurement tool that 
applied “objective metrics toward documentation of work, and to provide clearer insight to better 
meet clinical research program challenges and aid in balancing staff workload” (p. e536). Fifty-
one community-based research programs representing 30 states participated in the project, which 
took place over six consecutive months. According to Good, Hurley et al., a 2010 survey 
conducted by the ASCO Community Research Forum not only reinforced the need for a method 
to evaluate clinical trial related workload but was one of the top three of 12 proposed projects. In 
response, ASCO formed a work group to develop such a tool. After conducting a review of the 
literature and available tools the work group concluded that three characteristics of a workload 
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measurement tool should be simplicity, reproducibility and long-term usability. “The project 
focused only on clinical trial workload associated with patient-centered encounters or clinically 
focused efforts, defined as any in person protocol-required evaluation and management visit that 
was designated as required on the protocol study calendar/study plan,” but did not include 
regulatory-based workload or other non-clinical elements related to clinical trial work (Good, 
Hurley et al., 2016, p. e537). Two interrelated tools were used for the project: ASCO Protocol 
Acuity Scoring Worksheet, ASCO Clinical Trial Assessment Tool.  The ASCO tool was based 
on the WPAT (previously described) that had been in use for more than ten years. The acuity 
scoring worksheet, which consisted of a 4-point rating scale, would be used to calculate the trial 
complexity level from the least complex to the most complex. The assessment tool was a web-
based platform used to collect individual protocol and individual staff acuity scores but was 
programmed to use full-time equivalent (FTE) status instead of workdays per week used in the 
WPAT model. The protocol acuity score was multiplied times the number of patient encounters 
for each specific trial then was divided by the staff FTE value to yield the individual staff acuity 
score. Descriptive statistics accounted for self-reporting of data by all participating programs, 
and frequencies and percentages were used to summarize their findings. Additionally, to account 
for the heterogeneity of the participating program’s characteristics, the programs were grouped 
into categories to separate them by type and size of the program. Only FTE data were used to 
summarize staff acuity scores and patient encounters for each group and “data were reported as 
medians and ranges by patient status, trial sponsor, type of trial and staff title” (Good, Hurley et 
al., 2016, p. e538).  Ninety percent of the 51 research programs that participated provided all six 
months of workload data, two sites provided five months of data and three sites provided two, 
three, or four months of data respectively. The research programs reported a median accrual of 
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150 patients into clinical trials overall and a median of 37 open and actively enrolling trials. 
They “contributed clinical trial-associated workload data for 323 staff members in total…which 
represented 963 unique protocols and 165 unique sponsors” (Good, Hurley et al., 2016, p. e539). 
Six percent of the 323 staff members identified as teams of staff consisting of multiple members. 
Congruency in the assignment of the same protocol acuity rating was found for 461 protocols but 
a 1-point difference in 120 protocols and 2-point difference in 23 protocols were found. 
Variability in assigned acuity rating scores were found in 36% of industry trials, 17% of 
federally sponsored trials, 3% of academic-sponsored trials and 4% of trials with other sponsors 
(P<.001). The median acuity rating assigned to treatment trials was 3, cancer control trials was 2, 
correlative science trials was 1.5 and observational/registry trials was 1. Across all groups the 
highest median staff acuity scores were for those who had patients who were on study and 
receiving treatment relative to those with patients only on study follow-up. Higher median staff 
acuity scores were seen in treatment trials, compared to cancer control, observational/registry 
and prevention trials. Industry trials yielded higher median staff acuity scores than trials that 
were federally sponsored, academic-sponsored or had other type of sponsors. 
According to Coffey et al. (2011) “[t]he increasing use and complexity of multi-modality 
treatment regimes, the rising costs of clinical trials, the emphasis on the efficient use of available 
resources and adherence to Good Clinical Practice (GCP), and increasing regulatory 
requirements and demands for quality assurance/control, have resulted in an increased focus on 
workload issues” (p. 36). They indicated that the use of unproven methods or simple estimation 
for measuring workload may result in unrealistic expectations, excessive workload or inefficient 
use of resources. They described a pilot study of the Workload Measurement Instrument (WMI) 
that was developed because of the recognition of the importance for understanding the tasks, 
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time requirements and resources involved in effectively and efficiently conducting clinical 
research. The WMI “was seen as a means of providing a tool by which individuals could 
estimate more accurately the time and resources required to participate in clinical trials” (Coffey 
et al., 2011, p. 36).  The development of this instrument involved seven stages leading to the 
finalization of the trial related tasks to be assessed. The instrument applied concepts from two 
prior instruments that individually assessed workload and complexity of a trial. The WMI 
instrument developers divided the instrument into four modules representing the planning, 
implementation, data management and study close-out phases of a trial. Next, they applied the 
complexity rating dimension to the instrument. They further subdivided the implementation 
module into recruitment/treatment and treatment/follow-up to facilitate validating and linking the 
workload measurement with the complexity dimension. The prospective study only focused on 
research related activities and not those considered as clinical standard of care. Workload was 
only assessed for clinical research coordinators to keep participant characteristics homogenous 
and to facilitate collection of more precise workload data. Data collection was completed over a 
six-month period. The findings confirmed that all tasks and subtasks within modules 1, 2, 3 were 
valid, and what tasks or subtasks were completed more and less frequently for modules 1, 2a, 2b 
and 3.  Analysis of the data from modules 4 were not described because of the small number of 
studies that were in this phase. The aim of this prospective study was focused on validating what 
trial related tasks both increased the trial’s complexity and workload for each of the four phases 
of the trial conduct included in the modules. The purpose of the WMI was to determine what 
tasks or subtasks occurred in each of the four phases to allow examination of workload and 
complexity to inform on multiple different levels. 
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Several studies or pilot projects involving the testing of a workload measurement tool 
were described. Of these two were level II high quality quasi-experimental and four were level 
III good quality non-experimental studies. Despite that some of the pilot testing took place across 
multiple research facilities, none of their findings were considered generalizable, and emphasis 
was made for the application of these tools to reflect the heterogeneous characteristics of the 
research facility to ensure meaningful measurements of workload. Across all the studies, the 
tools used objective quantitative measurements to calculate trial complexity and workload. The 
literature suggested that complexity and workload measurement tools are useful in determining 
workload capacity for different phase trials, estimating staffing and budget requirements and for 
allocating more balanced workload for research staff. Measurement indicators used to calculate 
workload are essential in informing about the quality of work, efficient use of staff resources, 
necessary changes to existing processes, competency training related to trial task requirements 
and for supporting the evaluation of clinical trial performance. The literature confirms phase I to 
be the most complex level of trials.  
Theoretical Framework 
Two conceptual models were utilized as the framework for the development and 
implementation of this pilot project. The Institute for Healthcare Improvement (IHI) Model was 
used to guide the development of the project aims. This model incorporates the use of Plan-Do-
Study-Act (PDSA) cycle for testing and studying the change for improvement (Appendix C).  
IHI Model for Improvement 
The three fundamental questions from the IHI model guided the development of the 
project aims, measures to determine if change leads to improvements and changes to implement 
that result in process improvement (Institute for Healthcare Improvements, n.d.). Utilizing the 
A MEASURE TO DETERMINE ACCEPTABLE WORKLOAD  18 
PDSA cycle, the IHI model outlined four main components for the iterative process for testing 
and studying the change – the use of a quantitative workload measurement tool to assess trial 
complexity and workload.  
•  Step 1 (Plan) involves planning of testing and observation that includes a data 
collection plan 
• Step 2 (Do) involves small-scale testing of an intervention or change in process 
• Step 3 (Study) involves time to analyze the data and study the results 
• Step 4 (Act) involves making refinements to the intervention or process change based 
on information learned from the test (Institute for Healthcare Improvements, n.d.).  
Plan-Do-Study-Act  
 
According to Coury et al. (2017), the PDSA cycle is a commonly used model for 
implementing small tests of change to optimize process improvement in health care settings that 
might have untapped potential for pragmatic research. In contrast to clinical trials which 
“emphasize internal rather external validity, using highly controlled environments and selected 
populations…pragmatic studies are generally embedded in care delivery environments,” 
therefore making this an ideal model to use as the strategy for implementation of this pilot 
project (p. 2). Its advantage is it allows evaluation and refinements of an intervention to be made 
soon after it is implemented. 
Taylor et al. (2014) cited that there is mixed evidence on effective quality improvement 
interventions and many have concluded that such interventions may only be effective in specific 
settings. Additionally, they indicated that research findings emphasized the effect that the local 
context has on the success of an intervention, citing that stand-alone interventions are unlikely to 
deliver consistent improvements and instead require multi-faceted approaches that are developed 
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iteratively to adapt to the predictable and unpredictable changes that occur over time and within 
a complex social system. They further cited that the PDSA cycle is one such method for an 
iterative development of change, either used by itself or as part of a wider quality improvement 
approach, such as the IHI Model for Improvement (Taylor et al., 2014). 
Methodology  
Using the PDSA cycle, project implementation was divided into two stages. The first 
stage was project planning and the second was the implementation stage. During the planning 
stage, the project stakeholders were identified, the aims and objectives were developed, 
stakeholder roles, responsibilities and project timelines were established, the data collection plan 
was created, workload measurements for two sample protocols were performed and adjustments 
were made to the data collection plan and elements of the tool based on the initial measurements 
performed. 
The following were completed during the implementation stage: measurement of trial 
complexity and workload was completed for ten protocols that were active between 2011 to 2019 
inclusive, a job stress survey of the clinical trials unit personnel, and a review of protocol 
deviations reported for the ten protocols from the project sample.   
Project Setting & Population 
The pilot project was conducted on a moderate sized clinical trials unit located within an 
academic and tertiary healthcare institution. The unit consisted of three research managers, five 
clinical research nurses (CRN) and ten clinical research coordinators (CRC). The research staff is 
responsible for coordinating trials that were mostly phase I and investigating the use of cell-
based immunotherapies to treat patients with advanced stage cancer. Trial conduct involved 
physician investigators, multidisciplinary clinical teams, study sponsor teams (e.g., project and 
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data management), and three institutional oversight committees. Technical assistance was 
solicited from the institution’s Quality Improvement consultant for advice on certain elements 
related to the project, such as Lean principles and how to perform time measurements of work 
activities. A staff statistician was also consulted for advice on data collection and interpretation.  
Project Feasibility 
The Institutional Review Board of record (i.e., University IRB) granted an exemption for 
this quality improvement (QI) project. The project site’s IRB deferred to the IRB of record for 
the exemption for this QI project. The department of nursing education for the project site 
concurred with the project site’s IRB and permitted the project to proceed as planned. 
Additionally, the project aims and its implementation received the support from the project 
lead’s executive deputy director who functioned as the residency preceptor and the personnel 
from the clinical trials unit who were stakeholders for the QI project implementation. 
Minimal expense was incurred for this pilot project. All of the data collection worksheets 
and instruction guides were created with Microsoft (MS) Word, and data were entered into MS 
Excel for the eventual data review and interpretation.  This software application was a work 
issued tool that was available to the project lead, research managers and research staff prior to 
the start of the project and therefore did not generate any additional expenses.  
There were some anticipated barriers for the implementation of this pilot project. The 
integration of project activities into the existing workflow of the research managers and staff 
(i.e., CRNs, CRCs) who had many competing work priorities was a concern. As stakeholders 
they participated in the development of the data collection tools and participated in data 
collection and other project related activities. These barriers were mitigated with scheduled 
project meetings and use of data collection tools that could be completed electronically and 
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remotely during the approximately two-month period when the data collection occurred. The 
completion of data collection was not extremely time consuming for the stakeholders nor were 
these extremely time sensitive. The data collection activities for this project were completed in 
approximately two months with all of the actual data collection being completed remotely. The 
research managers and staff had access to the unit’s trial master files and share drive via secure 
remote access that facilitated their ability to complete their administrative work duties and 
project related data collection off site.  
The other anticipated barriers were confidentiality and intellectual property concerns. 
Confidentiality considerations pertained to the staff who participated in the pilot project, as well 
as with the use of study participant information. To maintain anonymity of staff and study 
participants only deidentified data were used for data collection. The project site’s legal 
representative confirmed that there was no intellectual property issue since this was not a 
research project.  
There was also an ethical concern related to the potential risk for bias because of the dual 
role I had as the director of the unit and graduate student conducting the QI project. It was 
crucial that my role as the director did not intersect with my role as the project lead. This was of 
primary concern with the workload survey category pertaining to job satisfaction. To reduce 
bias, stakeholders were involved with the development of the data collection tools pertaining to 
workload measurement to ensure that it represented the specific needs of their unit. Objective 
tools such as OPAL and an established job stress survey available in the public domain were 
used to collect data for workload measurements and job stress factors. With respect to the 
survey, steps were taken to preserve the anonymity of the respondents by having them return 
their completed questionnaire via email. The questionnaire which did not include any identifiers 
A MEASURE TO DETERMINE ACCEPTABLE WORKLOAD  22 
were then immediately saved into an electronic folder and the email was then deleted. The 
review of the responses took place after all of the completed questionnaires were filed. The 
demographic questions included in the survey pertained to educational background and research 
experience and did not include questions that would likely disclose the identity of the 
respondents.  
The COVID-19 pandemic occurred at the onset and persisted throughout the duration of 
the data collection for this project. Due to many significant changes to the institution’s clinical 
workflows resulting from the pandemic and social distancing requirements, the time study 
component for this pilot project was permanently eliminated. Other components for the project 
were unaffected by the COVID-19 crisis.  
Trial Complexity & Workload Measurement  
A comparison was made between the various instruments studied to measure trial 
complexity and workload in the clinical trial setting from the description in the literature. OPAL 
was selected as the tool for this pilot project based on the guiding principles that it was easy to 
use, adaptable to the local context of the clinical trials unit where the project took place, and 
measured trial complexity. Three measurements were generated using OPAL: trial complexity, 
case workload, and total workload. Workload measurements were performed by two of the unit’s 
research managers for ten clinical trial protocols using OPAL.  They collaborated with the 
project lead in recreating the list of central processes (CP) and special procedures (SP) to reflect 
the trials in our unit (Appendix B). They performed initial measurements for two trial protocols, 
then met with the project lead to discuss modifications necessary for clarifications for the 
calculation of case workload. Refinements to both the workload measurement worksheet and 
instruction guide were made to facilitate this need. 
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A trial complexity score was assigned to each of the ten protocols using the OPAL 
pyramid scale (Appendix D). The pyramid scale complexity level is based on the phase of the 
trial and a set of criteria that include the number of occurrences of SPs and CPs. We modified the 
list of CPs and SPs to make it more representative of the trial activities for our unit.  
The original calculation for case workload involved multiplying the OPAL complexity 
score by the number of study participants in either the active or follow-up phase of the trial.  
Calculation of the total workload involved the addition of the OPAL complexity score plus the 
case workload score. The case workload score represented patient management and the total 
workload score was associated with study management. For the convenience of the pilot testing 
of OPAL we multiplied the complexity by only the number of patients for the trial sample size.   
We were interested in learning if we could better assess the trial complexity by adding 
points for every occurrence of a SP that we identified as unique to certain protocols (Appendix 
B). We modified the calculation of case workload by adding the complexity score plus the 
additional points for SP and multiplied this by the number of patients for the trial sample size 
yielding new case workload scores for the ten protocols in our sample. 
Protocol Deviations 
In parallel, additional stakeholders were also solicited to participate in data collection of 
protocol deviations that were reported for each of the ten trial protocols from our sample. An 
index of all protocol deviations was available from each protocol’s trial master file. The 
regulatory manager from the unit created copies of the tables that indexed all of the protocol 
deviations that were reported to date. Review of protocol deviations was an important concept 
for examining errors made during protocol execution that would inform about factors affecting 
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accuracy, competency of staff and factors that contribute to work stress. We also wanted to learn 
if any of the deviations impacted patient safety or study outcome.   
Job Stress Survey 
A workload survey was assembled using four categories from a job stress questionnaire 
created by the National Institute for Occupational Safety and Health (NIOSH) that was available 
in the public domain. The NIOSH Generic Job Stress Questionnaire is a validated instrument that 
included multiple dimensions of job stress that could be used in total or individually to construct 
a separate survey questionnaire. Four categories from this instrument were used to develop the 
workload survey for this project.  
• Job Requirements 
• Workload and Responsibility 
• Mental Demands 
• Job Satisfaction 
Questions from the NIOSH instrument representing these dimensions were included in 
the survey. The intent of the survey was to examine if there were any correlations between the 
responses to the survey and factors impacting workload. In particular, this was related to the 
impact on staff efficiency and work stress. Instructions accompanying the survey questionnaire 
was emailed to 18 staff members of the clinical trials unit. The questionnaire was designed to be 
completed electronically and returned to the project lead via email. The questionnaire did not 
require any identifiers that would discourage honest responses to each of the questions, most 
especially those pertaining to job satisfaction. A minimal amount of demographic information 
pertaining to educational background and research experience was queried on the survey but 
none that would likely compromise the anonymity of the respondents.  The participants were 
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requested to return their completed survey form via email and each form was blindly copied 
from the email into an electronic folder and were assigned a file number based on the sequential 
order in which these were received. This was to keep accounting of responses for follow-up 
purposes. The email from the participant was deleted after their completed questionnaire was 
filed. All correspondences related to the survey were conducted using the project lead’s school 
email account.  
Outcomes Measurement & Findings 
The outcomes and interpretation of the findings were guided by Lean principles. 
According to Sweeney (2017), Lean incorporates the “philosophy of kaizen, or the creation of a 
culture of continuous improvement” (p. 9). In measuring the outcomes of our aims and 
interpreting the findings we utilize the concepts of Muda, Mura and Muri from Lean to focus our 
attention on the opportunities for process improvement changes. Each of these concepts of Lean 
addresses fundamental areas for process improvements. “Muda represents waste in its most 
physical form,” and “[t]he objective with waste reduction and elimination is to clearly separate 
the value-added activities that are identified as wasteful or non-value-added” (Sweeney, 2017, p. 
7).  “Mura is waste in the sense of unevenness,” because “[u]nevenness in workflow can result in 
unnecessary downtime or periods of unnecessary stress on equipment, systems, and workforce” 
(Sweeney, 2017, p. 8).  “Muri is a failure to understand capabilities or to succumb to the effects 
of overburden” (Sweeney, 2017, p. 8). 
Objective 1/Outcome 1 
The first thing we were trying to accomplish was to show that we could measure trial 
complexity. We used OPAL to measure complexity for ten trial protocols that were conducted 
between 2011 and 2019 inclusive. What we learned was that we could determine trial complexity 
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using OPAL. Of our ten trial protocols, six were phase I, one was phase I/II and three were phase 
II.  All phase I and I/II trials scored a complexity level of eight (8) that was consistent with the 
literature noting phase I trials as the most complex. It is also notable that most of the trials 
conducted in this research unit are phase I trials. 
Objective 1/Outcome 2 
We wanted to see if the number and frequency of trial procedures affected the complexity 
and workload scores. We completed two calculations for case workload using the original and a 
modified formula to generate original and new workload scores. What we found was that the 
new workload scores were greater than the original case workload scores with a mean of 416.5 
and 173.2 respectively (Table 1). The modified calculation for case workload then resulted in 
higher total workload scores. 
Table 1 











Mean 7.70 173.20 180.90 416.50 424.20 
Median 8.00 164.00 172.00 419.00 427.00 
SD .483 54.121 54.098 178.727 178.854 
Minimum 7 98 105 201 208 
Maximum 8 264 272 792 800 
 
We measured the difference between the original and new case workload scores using a 
paired t-test. To illustrate the difference, we plotted that scores on a graph (Figure 1). The paired 
t-test strongly suggests a highly significant difference in the mean values of the two scores with a 
P<.001. This suggested that the new case workload scores captured the true complexity of these 
trials.  
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Objective 1/Outcome 3 
We were also interested in learning if we could create a threshold representing an  
Figure 1 
Original & New Case Workload Scores 
 
Note. Y-axis shows the range of case workload scores. X-axis shows the original and new case workload scores for 
all ten trial protocols from our project sample. 
acceptable distribution of work. We plotted the mean case workload scores and values of 1 SD 
and 2 SD on a graph (Figure 2). Using a random selection of two case workload scores from our 
sample of ten trials we calculated the workload scores for four simulated CRCs and plotted this 
on the graph to see whether the simulated workload scores were extreme (above 1 SD) or 
acceptable (within 1 SD). If scores lie within 1 SD of the mean this suggested an acceptable 
distribution of work, while those above would be considered extreme. To note, since our project 
sample only contained ten trial protocols the scores were not precise so measurements should be 
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replicated using a larger sample. Nevertheless, we were able to obtain useful information to 
inform on a balanced distribution of work. 
Objective 2 Outcome 
We wanted to identify three factors that impact staff workload. When we examined the 
original case workload against the new workload scores (Figure 1), we saw a significant increase 
in the scores, on the average a 2.3-fold difference suggesting the volume and frequency of trial 





Note. Y-axis represents the range of case workload scores. X-axis represents the clinical research coordinators 
(CRC) simulated case workload scores. 
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Objective 3 Outcome 
We wanted to identify four factors that affect efficiency and contribute to job stress. We 
conducted a workload survey that collected a limited amount of demographic data pertaining to 
staff educational background and work experience. The largest proportion of staff had either a 
healthcare or science related background. Of these two groups, most of the staff with healthcare 
background had prior jobs in clinical research and 6 to 10 or greater years of experience in 
clinical research. 
Below were the more frequent responses from the job requirement category of the survey 
(Appendix E). The more extreme of these responses are in bold. We interpreted these responses 
to mean that although their job was challenging, their skills were often matched with the tasks 
they needed to complete, suggesting that skill level should match the complexity of the work 
tasks to be efficient.  
• ~ 47% = required to work fast sometimes 
• ~43% = required to work hard fairly often 
• ~37% = had little time to get things done sometimes 
• ~41% = had a great deal to be done sometimes 
• ~41% = had a great deal to be done fairly often 
• ~58% = had marked increase in workload sometimes 
• ~43% = had marked increase in amount of concentration required on the job 
fairly often 
• ~43% = were given a chance to do the things they do best fairly often 
•  50% = used skills from previous experience and training fairly often 
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The responses from the workload and responsibility category (Appendix F) indicated that 
although ~62% of the staff in this unit had a lot of work, 50% of them had a lot of time to 
complete their work suggesting that there is an even distribution of work. Fifty-nine percent 
indicated having a lot of projects, assignments or tasks suggesting that this may be an area 
requiring further examination of skill-mix. 
•  50% = experience a little slowdown in workload 
• ~68% = have some time to think and contemplate 
• ~62% = have a lot of workload 
•  50% = have a lot of time to do all their work 
• ~59% = have a lot of projects, assignments or tasks 
• ~56% = have some lulls between heavy workload periods 
From the mental demands category (Appendix G), approximately 68% indicated that 
their job required a great deal of concentration and about 80% were required to remember many 
different things. We interpreted this to mean that although their workload is likely balanced their 
work is very challenging and complex. 
With respect to job satisfaction (Appendix H), 50% indicated they were very satisfied and 
the other 50% indicated they were somewhat satisfied. Approximately 87% indicated that they 
would take the same job over again and 68% would choose a similar job if they had other 
choices. This suggested that their current work and workload were not affecting overall job 
satisfaction. 
When we reviewed the protocol deviations that were reported for four of the ten protocols 
from our project sample, we noted that the higher numbers of deviations pertained to missed tests 
or procedures and study visits or procedures completed outside of the protocol specified window. 
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This suggested that the volume and frequency of protocol required tests and procedures affected 
the accuracy and efficiency of the staff’s work performance. This is consistent with the literature 
that indicated that humans who are overburdened with work may hurry their performance, 
commit more errors and have poor awareness of their surroundings. It is notable that none of 
these protocol deviations were determined to affect patient safety or study outcome. 
Objective 4 Outcome 
What we learned from our findings is that the volume, frequency and complexity of trial 
work activities does affect the clinical trial performance in our unit. This was evident from our 
workload assessments, as well as the number of protocol deviations that we noted from our 
review. We also learned that the volume of work, complexity of trial related tasks, aggressive 
timelines, prior work experience, skill level and strategic use of staff skill mix should be factors 
to assess because they do impact staff efficiency and can contribute to work stress. For example, 
matching skill level to the complexity of the task required for staff to complete would result in a 
more efficient use of staff resources. We also learned that there is value in using quantitative 
measurements to assess workload.  More importantly we learned that use of established 
conceptual models such as the IHI Model for Improvement, PDSA and Lean are more reliable 
and sustainable methods for testing and studying change directed at process improvements.  
As a result of our pilot project, we are piloting the use of a staff effort calculator that we 
created using MS Excel. The calculator is used to calculate staff effort dedicated to each of their 
assigned protocols based on hours worked in a 40-hour week. This calculator can also be used to 
perform a cost benefit analysis for staffing requirements based on the skill level required for the 
role and responsibilities for each trial protocol.  
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Limitations 
The overall limitation for this pilot project was the limited sample size of the protocols 
used for measuring trial complexity and workload. We also did not calculate case workload 
using active and follow-up patients actually enrolled in the trials. Another limitation was that we 
only measured trial complexity but not the complexity of the individual tasks themselves. This 
would be informative in determining whether volume of work, the complexity of the task or 
both, impact clinical trial performance and efficiency. We also had time restrictions for 
completing repeat testing of the tool and performing additional measurements. Finally, due to 
concerns of confidentiality the responses to the survey pertaining to job satisfaction may not 
have been as candid. 
Conclusion 
The most important lesson we learned from this pilot project was that there are 
established and more exquisite methods for testing and studying changes for process 
improvement. I recommend that concepts from the IHI Model for Improvement, PDSA and Lean 
be used in this unit for implementation and evaluation of process improvement changes as these 
are more sustainable comprehensive methods in comparison to single-bullet approaches. 
Consistent evaluation of our operational model needs to be conducted to determine when process 
improvement changes are warranted. Use of quantitative methods to calculate staff effort and 
work capacity will result in more accurate estimation of staffing and budgetary requirements.  
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Appendices 
Appendix A 
Key Literature Synthesis and Appraisal 
Author Title Synthesis Findings Appraisal 
Smuck et al. (2011)  Ontario protocol assessment level: 
Clinical trial complexity rating tool 
for workload planning in oncology 
clinical trials. 
• Aim - to demonstrate that OPAL 
was reliable, and scoring was 
consistent across clinical trial 
protocols and trials sites 
• OPAL workload measurement 
tool that rated protocol 
complexity based on a pyramid 
scale and calculated workload 
scores 
• Tool developed by experience 
group of clinical trial managers  
• Guiding principles for tool 
development were – easy to 
apply, measured work of clinical 
trial professionals, useful for 
calculating workload capacity, 
included all trial phases, and not 
intended for academic review 
• Complexity levels based on trial 
phase and protocol activities – 
central processes and special 
procedures 
• Calculation of workload score 
based on OPAL complexity level 
• Tool tested in 17 participating 
cancer clinical trials sites with 
heterogenous characteristics 
• 176 OPAL assessments were 
completed for 27 protocols  
 
• From the 176 assessments 
completed, analysis of the score 
variance of 1.5 was considered 
acceptable on the basis of 
research practice models and 
participation in correlative 
studies 
• Two trials were rated with a 
variance of 3.5 
• Misinterpretation of the 
definition of special procedures 
produced higher OPAL scores 
that indicated that OPAL needs 
to be applied consistently at the 
site and be based on local 
practices to produce measurable 
site workload information 
Level III – Good Quality 
Non-experimental study 
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Author Title Synthesis Findings Appraisal 
Sarmento & Silvino (2017) Measuring workload of clinical 
trials: Transcultural adaptation and 
validation to portuguese language of 
Ontario protocol assessment level 
(opal). 
• Aim – to perform Portuguese 
transcultural adaptation and test 
its validity and reliability  
• OPAL tool translated to 
Portuguese 
• Pretest of translated tool 
performed on 15 fictitious 
protocols to define workload 
score to set as the gold standard 
for evaluating psychometric 
capacity of the tool 
• Final version tested for reliability 
and validity 
• Numerical data analyzed using 
descriptive statistics  
• Concordance of workload scores 
pertaining to different observed 
items analyzed using inferential 
statistics 
• Confidence interval 95% 
• Analysis of concordance of 
observed items included 
differences of intra- and inter-
observer variability against the 
average result 
• High intra- and inter-observer 
concordance (p,0.0001) 
• High level of intra-observer 
concordance with ICC scores 
between 0.987 and 0.934 
• High level of inter-observer 
concordance compared to the 
gold standard score with an 
ICC.0.949 demonstrating high 
level of validity of the score.  
• Concluded after analysis that 
adapted tool met the needs of the 
users in calculating workload but 
needs to be used consistently and 
other factors that affect work 
must also be evaluated  
 
Level II – High Quality 
Quasi-experimental study 
Milani et al. (2017) How many research nurses for how 
many clinical trials in an oncology 
setting? Definition of the Nursing 
Time Required by Clinical Trial-
Assessment Tool (NTRCT- AT). 
• Aim – to evaluate NTRCT-AT as 
a means to measure workload 
expressed in time spent to 
complete trial associated core 
activities 
• Time measurements used to 
calculate total clinical trials 
nursing time required per patient 
enrolled in a trial 
• Participants comprised of 7 
Italian clinical research nurses 
• Research nurse team identified 
aim and study methods 
• A list of 30 core activities were 
selected for time measurements – 
11 pertaining to study activation 
and the remaining to study 
conduct 
• Time measurements of core 
activities performed by 
independent observer  
• Pilot testing conducted in one 
research facility  
• All activities were timed for all 
research nurses to reduce 
individual variability 
• Compared the total nursing time 
required by the trials annually 
(1,254, 578 minutes/year) with 
the total number of working days 
required in theory and the actual 
worked days showed a greater 
theoretical workload in hours per 
year (average 11.13 hours for 
one year assessed) 
• The research nurse participants 
felt this to be an accurate 
reflection of their current 
situation of excessive workload 
and difficulty in carrying out all 
necessary activities 
Level III – Good Quality 
Nonexperimental study 
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Author Title Synthesis Findings Appraisal 
• Tool tested retrospectively on 
141 clinical trials 
• Provides a quantitative 
measurement of workload that 
trial work activities represent in a 
workday 
Good et al. (2013) Measuring clinical trial-associated 
workload in a community clinical 
oncology program. 
• Aim – to evaluate an acuity-based 
workload measurement tool 
(WPAT) developed by WCCOP 
• Patient Classification - classified 
trial participants into two 
categories – on-study or off-study  
• Total number of on- and off-
study participants constituted the 
overall workload 
• On-study group subcategorized 
into active treatment and off-
treatment 
• Protocol Classification – protocol 
classified as either treatment-
focused or cancer control-focused 
and ranked based on 6 workload-
related determinants  
• Acuity scores assigned to 
individual clinical trials 
according to their estimated 
workload ranging from 1-
observational, 2-requiring oral 
agents with minimal toxicity 
potential, 3-chemotherapy with 
increased toxicity potential, 
complex drug regimens high 
toxicity potentials 
• Calculated individual research 
nurse workload scores monthly 
for 11 years by multiplying 
number of patients per trial by the 
assigned acuity score assigned to 
trial 
 
• Review of acuity score data 
across an 11-year timespan 
confirmed clinical trial 
complexity had increased 
• Treat-focused trials acuity scores 
increased by an annual average 
of 65% versus cancer control-
focused trials by 181% from 
1999 – 2009 
• Treatment trial 11-year average 
acuity score was 30.6, with 
annual average ranging from 
19.3 to 45.6 between 2000 – 
2008 
• Cancer Control trial annual 
acuity increased from 8.97 to 
69.8 from 2001-2006 
• Off-treatment acuity scores 
showed a 178% increase from 
2001-2009 
• The number of new patient 
enrollment and the number of 
patients on and off study 
increased over the 11-year 
timespan but as a result of 
monitoring workload and 
adjusting staffing needs based on 
acuity scores, the number of 
patients per FTE research nurse 
for new enrollments and patients 
on study decreased. The number 
of patients categorized as off 
study only slightly increased. 
Level III – Good Quality 
Nonexperimental study  
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Good et al. (2016) Assessing clinical trial-associated 
workload in community-based 
research programs using the ASCO 
clinical trial workload assessment 
tool. 
• Aims – to test a combination to 
two interrelated tools measuring 
protocol complexity and 
workload effort for clinical trials 
across multiple practice settings 
known as Clinical Trial 
Workload Assessment Tool 
• Two interrelated tools: ASCO 
Protocol Acuity Scoring 
Worksheet incorporated a 4-point 
protocol complexity rating scale 
where score of 1.0 = lower 
complexity/workload to 4.0 = 
complex trial with greater 
workload. ASCO Clinical Trial 
Workload Assessment Tool a 
web-based platform facilitated 
collection of clinical trial-
associated workload data. 
• 51 community-based research 
programs representing 30 states 
participated in this project 
• Clinical trial-associated monthly 
workload data were collected and 
entered into the web-based tool 
for 6 consecutive months 
• Project tool used refined and 
edited WPAT 4-point protocol 
scoring criteria developed 
previously by WCCOP 
• Protocol complexity assessed 
before assignment of protocol 
acuity score 
• Project tool accounted for two 
acuity metrics – protocol acuity 
and individual staff acuity scores 
• FTE status was programmed to 
be used instead of days worked 
per week  
• Patient encounters recorded in 
tool as either on-study but off 
treatment or off-study in follow-
up 
• Calculation of individual staff 
acuity score: number of patient 
encounters x protocol acuity 
score/staff member FTE value = 
individual staff acuity score  
• Descriptive statistics were 
computed for self-reported 
program characteristics and 
workload data, including staff 
acuity scores and number of 
patients encounters 
• Self-reported characteristics of 
the programs revealed a variety 
of types of programs, various 
degrees of experience and 
accrual volumes 
• 47% = federally funded 
• 14% = community hospital  
• 14% = non-academic hospital-
based private physician practice 
• 22% = non-hospital based private 
physician practice 
• 2% = private research network 
• 2% = other 
• Clinical trials experience ranged 
from 7 to 30 years 
• Clinical trial accrual median = 
150 patients 
• Open trial median = 37  
• Actively accruing trials ranging 
from 9 to 186 
• Research programs contributed 
clinical trial-associated workload 
data for 323 staff members, 
including RNs (49%), CRAs 
(28%), research coordinators 
(16%), administrators/managers 
(1%) 
• Data represented 963 unique 
protocols of which 604 observed 
patients on study treatment 
• Data represented 165 unique 
sponsors 
• 6% of staff identified as “teams 
of staff that included multiple 
members 
• Participating program were 
shown to be congruent in 
assignment of same protocol 
acuity rating to 461 protocols 
with patients on study treatment 
(76%) 
Level II – High Quality  
Quasi-experimental study 
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• Project only focused on core and 
consistent elements rather than all 
elements of the clinical trial-
associated workload  
 
• A difference of one point was 
found in 120 protocols (20%) 
• Two-point difference reported in 
23 protocols (4%) 
• Variability in assigned scores 
found in 36% on industry trials, 
compared with only 17% of 
federally sponsored trial, 3% 
academic-sponsored trials and 
4% of trials with other sponsors 
(P,.001). 
• Median acuity ratings assigned to 
treatment trials was 3; cancer 
control trials assigned median of 
2, correlative science trials 
assigned a median of 1.5 and 
observational/registry trials a 
median of 1 
• 96% of the 51 participating 
programs provided at least 5 
months  
• Response rate along with 
feedback form participants 
demonstrated that the tool was 
simple and easy to use and 
supported long-term feasibility 
and utility for community-based 
research programs and also 
minimized bias in the findings 
• Results support the idea that 
complexity of trial affects the 
work associated with trials 
• Establishing single-benchmark 
acuity score associated with 
number of patient encounters for 
FTE staff member to use as 
reference for community-based 
research programs required 
grouping programs under similar 
categories to allow comparison to 
the most applicable or similar 
types of program 
• Provides preliminary 
understanding of the complexity 
of the measurement of clinical 
trial-associated workload 
 
Coffey et al. (2011) Workload measurement instrument. • Aim – to collect data using 
Workload Measurement 
• Total of 414 modules were 
completed from 27 hospitals 
Level III – Good Quality 
Non-experimental study 
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Instrument (WMI) to validate the 
four WMI modules linked to a 
previously developed trial 
complexity assessment tool 
• WMI developed in 7 stages: 1-
development, 2-validation, 3-
revision of draft check list of trial 
related activities, 4-drafting of 
the WMI, 5-feasibility pilot 
study, 6-analysis, 7-revision of 
trial related tasks incorporated 
into the 4 modules 
• Prospective study focused only 
on research related activity and 
not those considered routine care 
• Workload only recorded for 
research staff working on trial 
and excluded investigators, 
pharmacists, day care staff, etc. 
due to belief that it would be 
difficult to collect accurate data 
from such a diverse range of staff 
– accepted limitation of study 
• Four WMI modules: Module 1-
planning stage, Module 2-
implementation stage, Module 3-
trial data management stage, 
Module 4-closure/final stage 
• Module 2 further subdivided in 
2a-recruitment and 2b-
treatment/follow-up 
• Data collection occurred over a 
6-month period 
• Modules 1 and 4 included any 
trials in planning and closure 
stage due to the small number of 
trials likely to be these stages 
during the 6-month data 
collection period 
• Modules 2 and 3 included trials 
covering as many tumor types, 
treatment modalities and study 
types to ensure an inclusive range 
of study activities 
• 36 studies were included in the 
prospective study 
covering 12 UK cancer research 
networks 
• Data completed for 35 of the 36 
trials included in study 
• Three centers did not complete 
the modules due to merger of 
networks, staff shortage or 
excessive workload issues 
• Assumption were made that 
research staff were experienced 
and trained; not involved in 
actual delivery of treatment; 
research activity was additional 
to standard treatment; hospital 
support services, standard 
equipment was 
available/accessible to staff 
• Module 1 = most frequently 
completed subtasks were those 
related to preparation/submission 
of documentation to ethics 
committees; lowest recorded 
tasks related to organizing and 
attending meetings other than in-
house meeting for information, 
training, and trial activation 
• Module 2a = most frequently 
completed subtasks related to 
screening for eligibility, 
informed consent, and sample 
preparation – consistent with 
expectations and personal 
experience of the project 
participants; least completed 
subtask was coordinating and 
verifying radiotherapy dose 
reductions and missed treatment 
– anticipated given very low 
numbers of radiotherapy trials 
included in the study 
• Modules 2a, 3 = most frequently 
completed subtask was 
completion of case report form, 
photocopying/sending trial 
documents, preparation and 
submission of trial amendments 
and updating study documents 
following amendments 
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• Two major revisions to WMI 
were identified as important: 1st 
change related to recognition of 
importance given to 
administration and 
communication by the 
collaborators and added as 
subtasks in modules; 2nd 
recombination of modules 2a and 
2b with specific sections related 
to consent, treatment and follow-
up incorporated into Module 2 
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Appendix B 
List of Central Processes and Special Procedures 
Central Processes 
OPAL score accounts for the items below 
Special Procedures 
One (1) point will be added to the OPAL 
score for each timepoint requiring the items 
below 
• Protocol and Informed Consent Form 
review 
• Submission to Institutional Committee(s) 
for review/approvals: initial review, 
amendments, continuing reviews, 
reportable events, exceptions/deviations 
• Study related training (e.g., SIV, EDC) 
• Triaging study related patient and 
provider inquiries  
• Screening and enrollment of subjects 
• Scheduling study patient visits 
• Coordinating study related procedures and 
visits  
• ECHO/MUGA 
• Insertion of apheresis catheter  
• Leukapheresis  
• Administration of Investigational Product 
(IP) – intravenous infusion 
• Preparation for monitoring visits and 
audits 
• Safety monitoring and reporting 
• Source documentation 
• Data entry and reconciliation 
• Electronic medication orders (Beacon) 
 
• Antigen Expression Testing  
• Bone Marrow Biopsy  
• Tumor Biopsy  
• Nuclear Imaging  
• Neuro Evaluation  
• Insertion of specialty catheter for 
intrapleural, intraperitoneal or 
intratumoral administration of IP  
• Administration of IP – intrapleural and 
intraperitoneal infusion or intratumoral 
injection  
• Lymphodepleting chemotherapy  
• Retreatment – planned retreatment of IP 
after the initial study treatment at Day 0  
• Fractionated dosing or multiple 
administration study visits 
• Multiple treatment cohorts 
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Appendix C 
 
Note. IHI Model for Improvement. Reprinted with permission from John Wiley and Sons. Copied from the Institute 
for Healthcare Improvement. Science of improvement: Testing changes. IHI n.d. 
http://www.ihi.org/resources/Pages/HowtoImprove/ScienceofImprovementTestingChanges.aspx 
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Appendix D 
OPAL Pyramid Scale 
 
Note. The Ontario Protocol Assessment Level (OPAL) pyramid scale. Copied from “Ontario Protocol Assessment 
Level: Clinical Trial Complexity Rating Tool for Workload Planning in Oncology Clinical Trials”, by Smuck, B. et 
al., 2011, Journal of Oncology Practice, 7(2), p.82. Copyright 2011 by American Society of Clinical Oncology. 
Reprinted with permission.  
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Appendix E 
Job Stress Questionnaire Dimension 1 
Job Requirements: 





How often does your 
job require you to 
work very fast? 1 4 8 4   
How often does your 
job require you to 
work very hard? 1 1 5 7 2 
How often does your 
job leave you with 
little time to get 
things done? 3 3 6 4   
How of often is there 
a great deal to be 
done? 1 1 7 7 1 
How often is there 
marked increase in 
the workload? 1 3 10 3   
How often is there 
marked increase in 
the amount of 
concentration 
required on your 
job?   2 6 7 1 
How often is there a 
marked increase in 
how fast you have to 
think? 1 4 6 5   
How often does your 
job let you use the 
skills and knowledge 
you learned in 
school? 3 3 3 5 2 
How often are you 
given a chance to do 
the things you do the 
best? 2 1 4 7 2 
How often can you 
use the skills from 
your previous 
experience and 
training?   3 4 8 1 
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Appendix F 




Hardly Any A Little Some A Lot A Great Deal 
How much 
slowdown in the 
workload do 
you experience? 1 8 7     
How much time 
do you have to 
think and 
contemplate?   1 11 3 1 
How much 
workload do 
you have?     6 10   
What quantity 
of work do 
others expect 
you to do?     9 7   
How much time 
do you have to 
do all your 




tasks do you 
have?     6 9 1 
How many lulls 
between heavy 
workload 
periods do you 
have? 1 5 9 1   
How much 
responsibility 
do you have for 
the future of 
others? 4 2 8 1 1 
How much 
responsibility 
do you have for 
the job security 
of others? 8 1 5 1 1 
How much 
responsibility 
do you have for 
the morale of 
others? 4 1 7 3 1 
How much 
responsibility 
do you have for 
the welfare and 
lives of others? 3 3 8 2   
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Appendix G 









great deal of 
concentration.  11 4   1 
My job 
requires me to 
remember 
many different 
things. 12 2   1 
I must keep my 
mind on my 
work at all 
times. 6 10     
I can take it 
easy and still 
get my work 
done.   2 9 5 
I can let my 
mind wander 
and still do the 
work.    1 9 5 
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Appendix H 
Job Satisfaction Dimension 4 
Job Satisfaction: Dimension 4   
   
Knowing what you know now, if 
you had to decide all over again 
whether to take the type of job you 
now have, what would you decide? 
I would decide without hesitation to take the 
same job. 14 
I would have some second thoughts. 2 
I would decide definitely not to take this type of 
job.   
   
If you were free right now to go into 
any type of job you wanted, what 
would your choice be? 
I would take the same job.  11 
I would take a different job. 5 
I would not want to work.   
   
If a friend of yours told you he/she 
was interested in working in a job 
like yours, what would you tell 
him/her? 
I would strongly recommend it. 15 
I would have doubts about recommending it.   
I would advise against it. 1 
   
All in all, how satisfied would you 
say you are with your job? 
I am very satisfied. 8 
I am somewhat satisfied. 8 
I am not too satisfied.   
 
